Welcome speech:
A. Arutyunov, Secretary General of the Eurasian Association of Therapists (Moscow, Russia)
T. Nurgozhin, Rector of Asfendiyarov Kazakh National Medical University (Almaty, Kazakhstan)
Optimal strategies for protecting patients with atrial fibrillation (with Bayer’s support)
G. Arutyunov (Moscow, Russia)
Generalized data of the first Eurasian COVID-19 registry
E. Tarlovskaya (Nizhny Novgorod, Russia)
Anticoagulants, hormones, and target treatment of internal organs: not all swans are white
A. Arutyunov (Moscow, Russia)
Thromboembolia of the pulmonary artery and deep vein thrombosis
A. Sugraliev (Almaty, Kazakhstan)
Problem of comorbidity in regions with limited resources
K. Darbinian (Moscow, Russia)
Chair:
A. Arutyunov (Moscow, Russia)
Pulmonary artery thrombosis or embolism in COVID-19?
Marco Cattaneo (Milan, Italy)
Acute coronary failure in COVID-19 patients (15-minute presentation)
O. Kolodyazhnaya (Moscow, Russia)
Anticoagulant agents: dosing issues
A. Arutyunov (Moscow, Russia)
Interstitial fibrosis: persisting lung inflammation
M. Boldina (Nizhny Novgorod, Russia)
Chair:
A. Arutyunov (Moscow, Russia)
Pre-diabetes and sympathetic overdrive; challenges and threats of the modern world
G. Arutyunov (Moscow, Russia)
CVD triple risk management. What a doctor must know and be able to do?
A. Arutyunov (Moscow, Russia)
Prevention of cardiovascular accidents in patients with CHD
A. Arutyunov (Moscow, Russia)
Five steps to diagnosing CHD in today’s world
G. Arutyunov (Moscow, Russia)
Possibility to intensify anti-thrombotic therapy in patients with CHD based on the recommendations and evidence base
Ya. Orlova (Moscow, Russia)
How to give combined anti-thrombotic therapy to patients with CHD
O. Barbarash (Kemerovo, Russia)
Which patients with CHD should be given combined anti-thrombotic therapy? Patient with pre-existing coronary heart disease and myocardial infarction
A. Lebedeva (Moscow, Russia)
Which patients with CHD should be given combined anti-thrombotic therapy? Patient with coronary heart disease and myocardial infarction
N. Khasanov (Kazan, Russia)
Which patients with CHD should be given combined anti-thrombotic therapy? Patient with coronary heart disease and polyvascular disease
E. Tarlovskaya (Nizhny Novgorod, Russia)
How to efficiently help a patient with CHD? Assessment of anti-thrombolic therapy risks and their minimization
A. Komarov (Moscow, Russia)
Patient with CHD after revascularization. Drug titration
I. Yavelov (Moscow, Russia)
A. Arutyunov (Moscow, Russia), G. Arutyunov (Moscow, Russia), Ya. Orlova (Moscow, Russia), O. Barbarash (Kemerovo, Russia), A. Lebedeva (Moscow, Russia), N. Khasanov (Kazan, Russia), E. Tarlovskaya (Nizhny Novgorod, Russia), A. Komarov (Moscow, Russia), I. Yavelov (Moscow, Russia)
A. Arutyunov (Moscow, Russia), G. Arutyunov (Moscow, Russia), Ya. Orlova (Moscow, Russia), O. Barbarash (Kemerovo, Russia), A. Lebedeva (Moscow, Russia), N. Khasanov (Kazan, Russia), E. Tarlovskaya (Nizhny Novgorod, Russia), A. Komarov (Moscow, Russia), I. Yavelov (Moscow, Russia)
Chair:
A. Arutyunov (Moscow, Russia)
Target therapy
S. Zyryanov (Moscow, Russia)
COVID plasma treatment
A. Boyarkov (Moscow, Russia)
Antibodies as immune response in different age groups
V. Shustov (Moscow, Russia)
Chairpersons:
Sh. Zhangelova (Almaty, Kazakhstan)
A. Kaskabayeva (Semey, Kazakhstan)
High-risk thromboembolia of the pulmonary artery. Diagnostics and treatment
Zh. Urazalina (Semey, Kazakhstan)
Unsolved issues of chronic heart failure management
B. Zholdin (Aktobe, Kazakhstan)
Problems with diagnosing thromboembolia of the pulmonary artery when a patient suffers from chronic heart failure
A. Sugraliev (Almaty, Kazakhstan)
Chronic heart failure and diabetes mellitus: new facts (under SANTO’s support)
A. Rakisheva (Almaty, Kazakhstan)
Chair:
I. Bakulin (Saint-Petersburg, Russia)
Digestive organs damage in patients with COVID-19
I. Bakulin (Saint-Petersburg, Russia)
Lungs damage in patients with COVID-19
M. Boldina (Nizhny Novgorod, Russia)
CNS damage in patients with COVID-19
S. Khachatryan (Yerevan, Armenia)
Myocardial damage in patients with COVID-19
E. Tarlovskaya (Nizhny Novgorod, Russia)
Kidney damage in patients with COVID-19
M. Batyushin (Rostov-on-Don, Russia)
Chair:
G. Manushakyan (Moscow, Russia)
Progress of myocardial infarction and SARS-CoV2 infection accompanied with kidney dysfunction
A. Panasovets (Grodno, Belarus)
Serum levels of proinflammatory cytokines (interleukin-1 beta and interleukin-6) in patients with diabetic kidney disease tested during treatment
E. Savicheva (Kharkov, Ukraine)
Chair:
G. Arutyunov (Moscow, Russia)
From the strategy to tactics, from the medicine to a patient. Treatment of aged patients with AF
G. Arutyunov (Moscow, Russia)
Only heart attack? What else an aged patient with AF should be protected from
Ya. Orlova (Moscow, Russia)
A nephrologist’s view of kidney failure in patients with AF. How to save and protect?
M. Batyushin (Rostov-on-Don, Russia)
Chairpersons:
V. Salukhov (Saint-Petersburg, Russia)
S. Shustov (Saint-Petersburg, Russia)
Male aging-associated chronic androgen deficiency and myocardial revascularization
S. Shustov (Saint-Petersburg, Russia)
Vicious circle of thyroidal metabolism in patients with CVD
A. Volkova (Saint-Petersburg, Russia)
I. Abramova (Saint-Petersburg, Russia)
G. Allamova (Saint-Petersburg, Russia)
Sugar-reducing cardioprotectors: prospects for managing outcomes in patients with type 2 diabetes mellitus
V. Salukhov (Saint-Petersburg, Russia)
Chair:
G. Zhunusbekova (Almaty, Kazakhstan)
Initiatives for Hypertension and COVID Prevention Dedicated to the World Hypertension Day
G. Zhunusbekova (Almaty, Kazakhstan)
Efficacy of healing CVD. Challenges of 2021 the COVID-19 pandemic presents
E. Privalova (Moscow, Russia)
Chair:
N. Mitkovskaya (Minsk, Belarus)
Acute myocardial injury or ACS: differential diagnostics issues arising during the COVID-19 pandemic
N. Mitkovskaya (Minsk, Belarus)
Cardiovascular risks a comorbid patient with syncope faces
E. Grigorenko (Minsk, Belarus)
Comorbid patient with pericardial effusion
G. Arutyunov (Moscow, Russia)
Modern possibilities of curing chronic heart failure
E. Kurlyandskaya (Minsk, Belarus)
O. Polonetskiy (Minsk, Belarus)
Chair:
L. Manukyan (Yerevan, Armenia)
COVID-19 and liver
A. Kazinyan (Yerevan, Armenia)
Efficacy of famotidine in healing COVID-19
L. Manukyan (Yerevan, Armenia)
Metabolic syndrome and COVID-19
E. Agazhanova (Yerevan, Armenia)
Post-COVID sexual, psychological and emotional disorders
V. Shakhramanyan (Yerevan, Armenia)
Chairpersons:
G. Shopaeva (Almaty, Kazakhstan)
A. Sugraliev (Almaty, Kazakhstan)
Pregnant women with COVID-19: Kazakh experience
G. Abuova (Shymkent, Kazakhstan)
COVID impact on CV diseases
Plinio Cirillo (Naples, Italy)
Comparative clinicopathologic characteristic of lung damage: COVID-19 and other bacterial and viral pneumonias
A. Goncharova (Almaty, Kazakhstan)
Chair:
V. Skibitskiy (Krasnodar, Russia)
A doctor treating a patient with hypertension: errors, doubts, and misconceptions
V. Skibitskiy (Krasnodar, Russia)
Resistant hypertension: errors that can be avoided
A. Fendrikova (Krasnodar, Russia)
Hypertension and depression: what errors we commit
A. Skibitskiy (Krasnodar, Russia)
Chairpersons:
B. Kosherova (Karaganda, Kazakhstan)
A. Sugraliev (Almaty, Kazakhstan)
COVID-19 survivor and vascular damages
Tatsuo Shimosawa (Tokyo, Japan)
Tuberculosis amid the COVID-19 pandemic
A. Rakisheva (Almaty, Kazakhstan)
COVID-19 in pregnant patients
S. Kasenova (Almaty, Kazakhstan)
Chair:
A. Babin (Kishinev, Moldova)
Stomach mictobiota and acid-related disorders
A. Babin (Kishinev, Moldova)
Functional and genetic aspects of endothelial dysfunction to be considered to effectively cure patients with COPD of pulmonary hypertension
K. Martynyuk (Kishinev, Moldova)
Decompensation of chronic heart failure (diagnostics and treatment)
D. Lysiy (Kishinev, Moldova)
The Eurasian Association of Therapists invites medical specialists to the 12th EAT International Conference "Comorbid Patients in the Pandemic Era” on April 22, 2021. The conference will bring together medical scientists, physicians and other health care specialists from the Russian Federation, CIS countries, Europe and Asia. It will be held in Almaty city. Anyone can take part online.
The Conference will include symposiums, data blitz sessions, expert discussions, competitions between early-career researchers, abstract / poster competitions, and a virtual health care expo.
The Eurasian Association of Therapists is an independent association that provides an opportunity for members of the Eurasian medical community to exchange views and share experiences.
One of the Association’s main goals is to disseminate advanced achievements of therapy by providing access to foreign medical practices and knowledge.
Our Association holds free events for medical specialists letting them earn CME credit points.
Medical professional can become a member of the EAT expert community and get expanded access to materials on the website of our Association
Visit the website euat.ruThis event is organized for medical professionals: practicing physicians, residents, medical students.
Participation is free
Any specialist of the internal medicine can take part in the competition. Compliance with the requirements for participants and submission procedures is obligatory. See more information about the requirements in "Submission" section.
The broadcast can be viewed on this website; it will be available on the day of the conference – (April 22, 2021).